Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease

Primary Non-Adherence to Preventive Drugs and Associations with Beliefs About Medicines in Stroke Survivors

(2022) Annica Westberg et al.   Patient Preference and Adherence

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

(2022) Donald M. Lloyd-Jones et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials

(2021) Emily Herrett et al.   BMJ-British Medical Journal

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis

(2021) Laney K. Jones et al.   Implementation Science

Statins and muscle pain

(2020) Joseph V. Pergolizzi et al.   Expert Review of Clinical Pharmacology

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

(2020) Kausik K. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reasons for Nonadherence to Statins – A Systematic Review of Reviews

(2020) Marianne Vie Ingersgaard et al.   Patient Preference and Adherence

Community pharmacist interventions to improve adherence to lipid lowering medication and their influence on clinical outcomes: A systematic review and meta‐analysis

(2020) Ainhoa Oñatibia‐Astibia et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention

(2020) Maneesh Sud et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions

(2020) Rohan Khera et al.   Journal of the American Heart Association

Cardiology clinic visit increases likelihood of evidence‐based cholesterol prescribing in severe hypercholesterolemia

(2020) Nicole A. Groth et al.   CLINICAL CARDIOLOGY

Medical misinformation: vet the message!

(2019) Joseph A. Hill et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the patient and provider assessment of lipid management (PALM) registry

(2019) Michael G. Nanna et al.   AMERICAN HEART JOURNAL

Association between Lipid Testing and Statin Adherence in the Veterans Affairs Health System

(2019) Xiaoming Jia et al.   AMERICAN JOURNAL OF MEDICINE

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry

(2019) Corey K. Bradley et al.   Journal of the American Heart Association

PCSK9 Inhibition, Atherosclerotic Cardiovascular Disease and Health Economics: Challenges at the Crossroads

(2019) Lieven Annemans et al.   Journal of Clinical Lipidology

Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes

(2019) Kelly D. Myers et al.  

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidaemia and hypertension – an umbrella review of systematic reviews and meta-analyses (Preprint)

(2019) Patrick Timpel et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017

(2019) Rohan Khera et al.   CIRCULATION

The Evolving Future of PCSK9 Inhibitors

(2018) Robert S. Rosenson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mail order pharmacy use and adherence to secondary prevention drugs among stroke patients

(2018) William P. Neil et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years

(2018) Richard Ofori-Asenso et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience

(2018) Muhammed T. Gürgöze et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences

(2018) Ann Marie Navar et al.   JAMA Cardiology

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Statin drug interactions and related adverse reactions: an update

(2017) Stefano Bellosta et al.   Expert Opinion On Drug Safety

The impact of an appointment-based medication synchronization programme on chronic medication adherence in an adult community pharmacy population

(2017) S. B. Andrews et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction

(2017) Maria-Corina Serban et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction

(2017) John N. Booth et al.   Circulation-Cardiovascular Quality and Outcomes

Statin Adherence: Does Gender Matter?

(2016) Karen M. Goldstein et al.   Current Atherosclerosis Reports

Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012

(2016) Nathan D. Wong et al.   Journal of Clinical Lipidology

Automated Outreach for Cardiovascular-Related Medication Refill Reminders

(2015) Teresa N. Harrison et al.   Journal of Clinical Hypertension

Statin therapy and related risk of new-onset type 2 diabetes mellitus

(2014) Massimiliano Ruscica et al.   European Journal of Internal Medicine